* Prophase Labs Inc PRPH.OQ PRPH.O is expected to show a
rise
in quarterly revenue when it reports results on August 11.
* The New York City-based company is expected to report a
118.9% increase in revenue to $20.012 million from $9.14 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Prophase Labs Inc
is for
earnings of 18 cents per share. For the same quarter last year,
the company reported a loss of 5 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Prophase
Labs Inc
is $14, above its last closing price of $10.67.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2022 0.47 0.39 0.68 Beat 76.6
Dec. 31 2022 0.45 0.44 0.85 Beat 93.2
Sep. 30 2021 0.07 0.07 -0.26 Missed -471.4
Jun. 30 2021 0.34 -0.05 Missed -114.9
Mar. 0.20 0.21 0.27 Beat 31.7
31 2021
Dec. 31 2020 -0.02 -0.02 -0.23 Missed -1,050
This summary was machine generated August 9 at 13:30 GMT. All
figures in US dollars unless otherwise stated